Inventor
VAN VLIET KIM M
US12 patents
Patents
12 patentsUS10011640B2Jul 3, 2018
Capsid-modified rAAV vector compositions and methods therefor
UNIV FLORIDA42 citations97
US9725485B2Aug 8, 2017
AAV vectors with high transduction efficiency and uses thereof for gene therapy
UNIV FLORIDA62 citations97
US9611302B2Apr 4, 2017
High-transduction-efficiency RAAV vectors, compositions, and methods of use
UNIV FLORIDA67 citations97
US10294281B2May 21, 2019
High-transduction-efficiency rAAV vectors, compositions, and methods of use
UNIV FLORIDA21 citations93
US10934327B2Mar 2, 2021
Capsid-modified, RAAV3 vector compositions and uses in gene therapy of human liver cancer
UNIV FLORIDA6 citations84
US10815279B2Oct 27, 2020
Capsid-modified rAAV vector compositions and methods therefor
UNIV FLORIDA10 citations84
US11124544B2Sep 21, 2021
AAV vectors with high transduction efficiency and uses thereof for gene therapy
UNIV FLORIDA4 citations83
US12065467B2Aug 20, 2024
High-transduction-efficiency rAAV vectors, compositions, and methods of use
UNIV FLORIDA2 citations72
US11434260B2Sep 6, 2022
High-transduction-efficiency rAAV vectors, compositions, and methods of use
UNIV FLORIDA3 citations72
US10927150B2Feb 23, 2021
Recombinant AAV1, AAV5, and AAV6 capsid mutants and uses thereof
UNIV FLORIDA5 citations72
US12358954B2Jul 15, 2025
Capsid-modified rAAV vector compositions and methods therefor
UNIV FLORIDA1 citations64
US12570699B2Mar 10, 2026
Capsid-modified, rAAV3 vector compositions and methods of use in gene therapy of human liver cancer
UNIV FLORIDA0 citations62